Recently named by Fortune as one of the “World’s 50 Greatest Leaders,” Peter Diamandis is the Founder and Executive Chairman of the XPRIZE Foundation, which leads the world in designing and operating large-scale incentive competitions. He is also the Executive Founder of Singularity University.

As an entrepreneur, Diamandis has started over 25 companies in the areas of health tech, space, venture capital, and education. He is the Co-founder and Vice-Chairman of two public companies, Celularity and Vaxxinity. Dr. Diamandis is Co-founder & Chairman of Fountain Life, a fully-integrated platform delivering predictive, preventative, personalized, and data-driven health. Finally, he also serves as Co-founder of BOLD Capital Partners, a venture fund with half-billion dollars under management being invested in exponential technologies and longevity companies.

Diamandis is a New York Times Bestselling author of four books: Abundance – The Future Is Better Than You Think, BOLD – How to Go Big, Create Wealth & Impact the World, and The Future is Faster Than You Think. Most recently, he co-authored the #1 best seller LIFE FORCE with Tony Robbins, which chronicles the extraordinary healthcare and biotech revolution unfolding before our eyes.

He earned degrees in molecular genetics and aerospace engineering from MIT and holds an M.D. from Harvard Medical School. Diamandis’ favorite saying is, “The best way to predict the future is to create it yourself.”

Buy his new books, Longevity and Exponential Organizations 2.0

In this episode you will learn

Insights into the current state of research and technology in extending human lifespan, and what the future holds.
How to prepare your body and mind for achieving audacious goals, embracing the concept of 'moonshot thinking'.
How individuals and organizations can develop a mindset that encourages risk-taking and boundary-pushing for innovative success.
About the most recent breakthroughs and advancements in life extension and why they are promising.
The major challenges and obstacles that researchers face in the quest to extend human lifespan.